Devonian Health Group is trading 10.4% up at CA$11.15 after confirming on August 18, 2026, that its shares and warrants could begin trading on NYSE American as early as August 21, subject to final authorization and market conditions.
- The planned U.S. listing is linked to an underwritten public offering.
- The company will remain listed on the TSX Venture Exchange.
- The planned listing is the clearest catalyst for the move.